[Physiological and pathophysiological roles of the endothelin converting enzymes].
Emoto
Noriaki
N
Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology*; D001552:Benzazepines / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use; D015195:Drug Design; D000072396:Endothelin-Converting Enzymes; D006020:Glycopeptides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008666:Metalloendopeptidases; D051379:Mice; D018345:Mice, Knockout; D009203:Myocardial Infarction / Q000188:drug therapy; D063065:Organophosphonates / Q000627:therapeutic use; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
D001552:Benzazepines; D001572:Benzofurans; C086164:CGS 24592; C404932:CGS 35066; D006020:Glycopeptides; D063065:Organophosphonates; C405520:SLV 306; D013754:Tetracyclines; D013777:Tetrazoles; C089987:CGS 26303; C088494:WS 79089B; D010649:Phenylalanine; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes; C008890:phosphoramidon